港股异动丨华检医疗(1931.HK)逆势升近7% 两日大涨逾13%
格隆汇9月19日丨次新股华检医疗(01931.HK)近两日来持续拉升,累计升超13%。现大涨6.73%,报3.33港元,暂成交845万港元,最新总市值44.4亿港元。华检医疗控股有限公司是一家主要从事销售体外诊断产品(IVD)的中国公司。8月底华检医疗发布上半年业绩,收益人民币9.13亿元,同比增长434.1%,母公司拥有人应占溢利3.54亿元,同比增878.8%。值得注意的是,华检医疗绩后高开低走收跌6.6%。分析人士称,不管是从营收还是利润上来看,华检医疗的2019上半年,都有了长足的增长。另一方面来看,希森美康凝血产品贡献公司和威士达大部分收入,倘若希森美康减少供应或停止分销协议,公司业绩很可能变脸,遭受较大影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.